[1]罗孝全　唐　辉　冯　浩　陈　兵　孙　谋.lncRNA MIR4435-2HG的表达水平及甲基化状态与脑胶质瘤病理分级的关系[J].中国临床神经外科杂志,2021,26(01):26-28.[doi:10.13798/j.issn.1009-153X.2021.01.009]
　LUO Xiao-quan,TANG Hui,FENG Hao,et al.Relationship between expression level and methylation status of lncRNA MIR4435-2HG and pathological grade of gliomas[J].,2021,26(01):26-28.[doi:10.13798/j.issn.1009-153X.2021.01.009]
点击复制

lncRNA MIR4435-2HG的表达水平及甲基化状态与脑胶质瘤病理分级的关系()
分享到：

《中国临床神经外科杂志》[ISSN:1009-153X/CN:42-1603/TN]

卷:
26
期数:
2021年01期
页码:
26-28
栏目:
论著
出版日期:
2021-01-25

文章信息/Info

Title:
Relationship between expression level and methylation status of lncRNA MIR4435-2HG and pathological grade of gliomas
文章编号:
1009-153X（2021）01-0028-03
作者:
罗孝全　唐　辉　冯　浩　陈　兵　孙　谋
637000 四川，南充市中心医院神经外科（罗孝全、唐　辉、冯　浩、陈　兵、孙　谋）
Author(s):
LUO Xiao-quan;  TANG Hui;  FENG Hao;  CHEN Bing;  SUN Mou.
Department of Neurosurgery, Nanchong Central Hospital, Nanchong 637000, China
关键词:
脑胶质瘤; 长链非编码RNA; MIR4435-2HG; 基因启动子甲基化; 肿瘤病理分级
Keywords:
Glioma;  LncRNAMIR4435-2HG;  Methylation;  Pathological grade;  IDH1
分类号:
R 739.41; Q 786
DOI:
10.13798/j.issn.1009-153X.2021.01.009
文献标志码:
A
摘要:
目的 探讨长链非编码RNA MIR4435-2HG的表达水平及甲基化状态与脑胶质瘤病理分级的关系。方法 选取2019年1~12月手术切除的脑胶质瘤组织110例和颅脑损伤内减压术中切除正常脑组织20例（对照组）。采用实时荧光定量PCR和甲基化特异性PCR检测组织和血清MIR4435-2HG水平及甲基化状态。结果 110例胶质瘤中，低级别胶质瘤（WHO分级Ⅰ~Ⅱ级）65例，高级别胶质瘤（WHO分级Ⅲ~Ⅳ级）55例；IDH1突变46例。脑胶质瘤组织和病人血清MIR4435-2HG表达水平均明显高于对照组（P<0.05），而甲基化率明显低于对照组（P<0.05）。低级别胶质瘤组织和病人血清MIR4435-2HG水平明显低于高级别胶质瘤（P<0.05），而甲基化率明显高于高级别胶质瘤（P<0.05）。IDH1突变型胶质瘤组织和病人血清MIR4435-2HG水平明显低于IDH1野生型（P<0.05），而甲基化率明显高于IDH1野生型（P<0.05）。MIR4435-2HG甲基化组胶质瘤组织和血清MIR4435-2HG水平明显低于非甲基化组（P<0.05）。ROC曲线分析显示，血清MIR4435-2HG水平鉴别脑胶质瘤级别的曲线下面积为0.752（95%置信区间0.701~0.804），最佳截断值为1.98，灵敏度和特异度分别为65.0%和91.5%。结论 脑胶质瘤，尤其是高级别胶质瘤，血清MIR4435-2HG表达水平普遍升高，检测血清MIR4435-2HG水平有助于鉴别诊断脑胶质瘤级别。MIR4435-2HG转录受其基因甲基化水平的调控，并且与IDH1突变有关。
Abstract:
Objective To investigate the relationship between expression level and methylation status of lncRNA MIR4435-2HG and pathological grade of gliomas. Methods The expression levels and methylation status of lncRNA MIR4435-2HG in glioma tissues and serum obtained from 110 patients (glioma group) with gliomas who underwent microsurgery from January 2019 to December 2019 and in normal cerebral tissues and serum obtained from 20 patients (control group) with traumatic brain injury who underwent decompression were detected by real-time fluorescent quantitative PCR and methylation-specific PCR, respectively. Results Of 110 glioma patients, 65 patients were low-grade gliomas (WHO grade Ⅰ~Ⅱ) and 55 were high-grade gliomas (WHO grade Ⅲ~Ⅳ); 46 had IDH1 mutations. The expression levels of MIR4435-2HG in glioma tissues and glioma patients’ serum were significantly higher than those of the control group (P<0.05), and the methylation rates were significantly lower than those of the control group (P<0.05). The levels of MIR4435-2HG in glioma tissue and serum of low-grade glioma patients were significantly lower than those of high-grade glioma (P<0.05), and the methylation rates were significantly higher than those of high-grade glioma (P<0.05). The levels of MIR4435-2HG in glioma tissue and serum of IDH1 mutant glioma patients were significantly lower than those of IDH1 wild-type glioma (P<0.05), and the methylation rates were significantly higher than those of IDH1 wild-type glioma (P<0.05). The levels of MIR4435-2HG in glioma tissue and serum of the MIR4435-2HG methylated group were significantly lower than those in the non-methylated group (P<0.05). ROC curve analysis showed that the area under curve for serum MIR4435-2HG levels to identify the grade of glioma was 0.752 (95% CI 0.701~0.804); the best cutoff value was 1.98; the sensitivity and specificity were 65.0% and 91.5%, respectively. Conclusions The expression level of serum MIR4435-2HG is generally elevated in glioma patients, especially high-grade gliomas. The serum level of MIR4435-2HG is helpful for the differential diagnosis of glioma grades. The transcription of MIR4435-2HG is regulated by its gene methylation level and is related to IDH1 mutation of glioma.

参考文献/References:

[1] Han S, Liu Y, Cai SJ, et al. IDH mutation in glioma: mole-cular mechanisms and potential therapeutic targets [J]. Br J Cancer, 2020, 122(11): 1580-1589.
[2] Yang M, He X, Huang X, et al. LncRNA MIR4435-2HG-mediated upregulation of TGF-β1 promotes migration and proliferation of nonsmall cell lung cancer cells [J]. Environ Toxicol, 2020, 35(5): 582-590.
[3] Wesseling P, Capper D. WHO 2016 classification of gliomas[J]. Neuropathol Appl Neurobiol, 2018, 44(2): 139-150.
[4] Cao WJ, Wu HL, He BS, et al. Analysis of long non-coding RNA expression profiles in gastric cancer [J].World J Gastroenterol, 2013, 19(23): 3658-3664.
[5] Xu H, Zhang B, Yang Y, et al. LncRNA MIR4435-2HGpotentiates the proliferation and invasion of glioblastoma cells via modulating miR-1224-5p/TGFBR2 axis [J]. J Cell Mol Med, 2020, 24(11): 6362-6372.
[6] Reon BJ, Takao Real Karia B, Kiran M, et al. LINC00152 promotes invasion through a 3’-hairpin structure and associates with prognosis in glioblastoma [J]. Mol Cancer Res, 2018, 16(10): 1470-1482.
[7] 赵宇航，王泽芬，徐成仕，等. 人脑胶质瘤IDH1突变状态与MGMT启动子甲基化、P53和TERT突变相关性[J]. 中国临床神经外科杂志，2018，23（5）：339-342

相似文献/References:

[1]付　锴　江普查　宫　睿　王　伟.表达VASH1基因的人脑胶质瘤U-87MG细胞对化疗药物敏感性的变化[J].中国临床神经外科杂志,2016,(01):34.[doi:10.13798/j.issn.1009-153X.2016.01.012]
　FU Kai,JIANG Pu-cha,GONG Rui,et al.Effect of lentiviral vector-mediated VASH1 gene on chemosensitivity of human glioma U-87MG cells[J].,2016,(01):34.[doi:10.13798/j.issn.1009-153X.2016.01.012]
[2]谈胤求　陈谦学　张红波　吴　鹏　李云涛　王栋良　袁凡恩.长链非编码RNA PVT1对人脑胶质瘤U251细胞增殖能力的影响[J].中国临床神经外科杂志,2016,(10):608.[doi:10.13798/j.issn.1009-153X.2016.10.013]
　TAN Yin-qiu,CHEN Qian-xue,ZHANG Hong-bo,et al.Effect of lncRNA-PVT1 on proliferation of glioma U251 cells[J].,2016,(01):608.[doi:10.13798/j.issn.1009-153X.2016.10.013]
[3]崔焕喜,柳　琛.多模态MRI、神经导航和超声在脑胶质瘤术中的应用[J].中国临床神经外科杂志,2016,(11):721.[doi:10.13798/j.issn.1009-153X.2016.11.027]
[4]闫　珊　徐善才.多学科护理照顾模式对脑胶质瘤术后病人自我护理能力的影响[J].中国临床神经外科杂志,2017,(05):352.[doi:10.13798/j.issn.1009-153X.2017.05.026]
　YAN Shan,XU Shan-cai..Effects of multi-subjects nursing care model on self-care ability in patients with brain glioma after operation[J].,2017,(01):352.[doi:10.13798/j.issn.1009-153X.2017.05.026]
[5]罗似亮　夏之柏.脑胶质瘤病人脑脊液Midkine表达的临床意义[J].中国临床神经外科杂志,2017,(06):416.[doi:10.13798/j.issn.1009-153X.2017.06.017]
　LUO Si-liang,XIA Zhi-bo..Clinical meanings of midkine expression in cerebrospinal fluid of patients with gliomas[J].,2017,(01):416.[doi:10.13798/j.issn.1009-153X.2017.06.017]
[6]呼铁民　褚会松　田　甜　王昆鹏　杨国军　杨立军　王维兴.脑胶质瘤ADAM17与EGFR的表达及临床意义[J].中国临床神经外科杂志,2017,(08):557.[doi:10.13798/j.issn.1009-153X.2017.08.012]
　HU Tie-min,CHU Hui-song,TIAN Tian,et al.Expressions of ADAM17 and EGFR in gliomas tissues and their clinical meanings[J].,2017,(01):557.[doi:10.13798/j.issn.1009-153X.2017.08.012]
[7]汪超甲 综述　王　辉 审校.脑胶质瘤化疗现状及耐药机制的研究进展[J].中国临床神经外科杂志,2017,(11):791.[doi:10.13798/j.issn.1009-153X.2017.11.023]
[8]高剑峰　姚庆和　李晓辉　龙宇波　陈振波.脑胶质瘤miR-9、PPARγ表达水平及临床意义[J].中国临床神经外科杂志,2018,(01):17.[doi:10.13798/j.issn.1009-153X.2018.01.006]
　GAO Jian-feng,YAO Qing-he,LI Xiao-hui,et al.Expressions of miR-9 and PPARγ in human brain gliomas and their clinical meanings[J].,2018,(01):17.[doi:10.13798/j.issn.1009-153X.2018.01.006]
[9]刘　靖　吴立权　黄书岚.聚焦解决模式对脑胶质瘤术后病人自我管理效能感及生命意义的影响[J].中国临床神经外科杂志,2018,(03):208.[doi:10.13798/j.issn.1009-153X.2018.03.025]
　LIU Jing,WU Li-quan,HUANG Shu-lan..Effects of solution focused intervention on self-management efficacy and meanings of life in the patients with gliomas after surgery[J].,2018,(01):208.[doi:10.13798/j.issn.1009-153X.2018.03.025]
[10]刘　炎　杭春华.脑胶质瘤卒中误诊为脑动静脉畸形并出血1例[J].中国临床神经外科杂志,2018,(06):448.[doi:10.13798/j.issn.1009-153X.2018.06.025]

备注/Memo

备注/Memo:
2020-11-02收稿
更新日期/Last Update: 2021-01-25